list of glp 1 agonist approved and pending GLP-1 medications Evolution of GLP‐1 Receptor Agonists

The effect of exenatide on thyroid-stimulating hormone and thyroid volume

Recent reports show a range from around 900 per week to roughly 2,200 to 4,200 per month for several generic semaglutide launches

[174] An observational study on people with obesity and type 2 diabetes and heart failure with preserved ejection fraction, semaglutide had about a 42% lower risk of hospitalization for heart failure and all-cause death combined compared with sitagliptin

8 Gastrointestinal side effects are most common, particularly during medication initiation and with dose escalation

The combination of SGLT-2 inhibitors and GLP-1 RAs offer additive benefits in reducing cardiovascular and renal risk in patients with diabetes and should be considered

Best for: BMI 30-40, failed medical/behavioral management, not ready or higher-risk for surgery, seeking middle ground between medications and surgery